Report Detail

Request for Sample of this report

Other Global saRNA Synthesis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4731582
    • |
  • 13 August, 2026
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global saRNA Synthesis Service market size was valued at US$ 100 million in 2025 and is forecast to a readjusted size of US$ 346 million by 2032 with a CAGR of 19.3% during review period.
saRNA Synthesis Service refers to the customized production of long RNA constructs containing an RNA replicase-coding region, a subgenomic promoter, and a target protein-coding sequence. Using plasmid DNA or linear DNA as the template, service providers perform replicon and sequence optimization, in vitro transcription, 5′ capping, 3′ poly(A) tail construction, nucleotide modification, purification, bioburden control, and quality testing. saRNA constructs are generally longer and structurally more complex than conventional mRNA, creating higher requirements for DNA template integrity, long-transcript yield, full-length RNA content, double-stranded RNA impurity control, and potency testing. Major upstream inputs include plasmid or linear DNA templates, natural and modified NTPs, T7 RNA polymerase, cap analogs or capping enzymes, poly(A) polymerase, DNase, buffers, chromatography resins, ultrafiltration membranes, and single-use consumables. Major downstream customers include vaccine companies, biotechnology companies, pharmaceutical companies, academic institutions, CROs, and CDMOs. The industry's overall gross profit margin is approximately 45%-62%.
The global saRNA synthesis service market remains in transition from research validation to clinical development and commercial manufacturing. It is less mature than the conventional mRNA service market, but saRNA projects generally involve higher technical barriers, greater customer switching costs, and higher clinical project values. Current orders are concentrated in infectious disease vaccines, cancer vaccines, immunotherapy, and protein expression platforms. Research-grade and preclinical projects account for most order volume, while GMP projects contribute a larger share of revenue because they require process development, analytical method establishment, validation, and release testing. Regulatory approvals and commercial production of saRNA products have further demonstrated the manufacturability and regulatory feasibility of the modality.
Competition is shifting from the basic ability to synthesize long RNA toward comprehensive control of full-length RNA content, capping efficiency, poly(A) tail consistency, double-stranded RNA impurities, residual DNA, endotoxin, and biological potency. saRNA constructs contain long replicase-coding regions and are more susceptible to premature termination, template-dependent by-products, RNA degradation, and incorrect folding. Service providers must optimize template structure, magnesium concentration, NTP ratios, transcription temperature, capping methods, and purification routes for different replicon backbones. High-resolution chromatography, tangential flow filtration, low-dsRNA processes, and cell-based potency assays are becoming important differentiating capabilities.
Market growth is primarily driven by demand for low-dose vaccines, sustained protein expression, new cancer immunotherapies, and increased outsourcing of RNA therapeutic development. After entering cells, saRNA can use its encoded replicase to generate additional RNA copies, potentially achieving stronger or longer-lasting protein expression from a lower initial dose. Small and medium-sized biotechnology companies frequently lack long-RNA process development capabilities, dedicated manufacturing facilities, and GMP quality systems. They are therefore more likely to outsource sequence design, template production, IVT optimization, purification, and quality testing. Providers capable of supporting continuous scale-up from research batches to clinical and commercial manufacturing are more likely to secure long-term programs.
Industry development remains constrained by limited long-RNA stability, difficult process scale-up, incomplete standardization of analytical requirements, and long clinical conversion cycles. Different replicon backbones, antigen sequences, and nucleotide modification strategies can produce substantially different transcription yields, immunogenicity profiles, and in vivo expression levels, making universal manufacturing processes difficult to apply. Intellectual property associated with critical enzymes, capping technologies, modified nucleotides, and delivery systems may also increase licensing costs and supply chain complexity. In addition, the dose-sparing advantage of saRNA may reduce the mass of RNA required during commercial manufacturing. Future market growth will therefore depend more on project numbers, process development intensity, and high-value GMP services than on RNA volume alone.
This report is a detailed and comprehensive analysis for global saRNA Synthesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global saRNA Synthesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global saRNA Synthesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global saRNA Synthesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global saRNA Synthesis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for saRNA Synthesis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global saRNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, GenScript, Catalent, Lonza, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Wacker, Curia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
saRNA Synthesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Research Grade
Preclinical Grade
GMP Grade
Other
Market segment by Batch Scale
Micro Scale (≤1 mg)
Small Scale (>1–100 mg)
Pilot Scale (>100 mg–10 g)
Manufacturing Scale (>10 g)
Market segment by Nucleotide Composition
Unmodified saRNA
Modified saRNA
Market segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Other
Market segment by players, this report covers
Maravai LifeSciences
Danaher
GenScript
Catalent
Lonza
Thermo Fisher Scientific
Samsung Biologics
Recipharm
Wacker
Curia
Biomay
ARCALIS
VectorBuilder
Creative Biogene
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe saRNA Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of saRNA Synthesis Service, with revenue, gross margin, and global market share of saRNA Synthesis Service from 2021 to 2026.
Chapter 3, the saRNA Synthesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and saRNA Synthesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of saRNA Synthesis Service.
Chapter 13, to describe saRNA Synthesis Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of saRNA Synthesis Service by Type
    • 1.3.1 Overview: Global saRNA Synthesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global saRNA Synthesis Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Research Grade
    • 1.3.4 Preclinical Grade
    • 1.3.5 GMP Grade
    • 1.3.6 Other
  • 1.4 Classification of saRNA Synthesis Service by Batch Scale
    • 1.4.1 Overview: Global saRNA Synthesis Service Market Size by Batch Scale: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global saRNA Synthesis Service Consumption Value Market Share by Batch Scale in 2025
    • 1.4.3 Micro Scale (≤1 mg)
    • 1.4.4 Small Scale (>1–100 mg)
    • 1.4.5 Pilot Scale (>100 mg–10 g)
    • 1.4.6 Manufacturing Scale (>10 g)
  • 1.5 Classification of saRNA Synthesis Service by Nucleotide Composition
    • 1.5.1 Overview: Global saRNA Synthesis Service Market Size by Nucleotide Composition: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global saRNA Synthesis Service Consumption Value Market Share by Nucleotide Composition in 2025
    • 1.5.3 Unmodified saRNA
    • 1.5.4 Modified saRNA
  • 1.6 Global saRNA Synthesis Service Market by Application
    • 1.6.1 Overview: Global saRNA Synthesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Pharmaceutical and Biotechnology Companies
    • 1.6.3 Academic and Research Institutes
    • 1.6.4 Other
  • 1.7 Global saRNA Synthesis Service Market Size & Forecast
  • 1.8 Global saRNA Synthesis Service Market Size and Forecast by Region
    • 1.8.1 Global saRNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global saRNA Synthesis Service Market Size by Region, (2021-2032)
    • 1.8.3 North America saRNA Synthesis Service Market Size and Prospect (2021-2032)
    • 1.8.4 Europe saRNA Synthesis Service Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific saRNA Synthesis Service Market Size and Prospect (2021-2032)
    • 1.8.6 South America saRNA Synthesis Service Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa saRNA Synthesis Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Maravai LifeSciences
    • 2.1.1 Maravai LifeSciences Details
    • 2.1.2 Maravai LifeSciences Major Business
    • 2.1.3 Maravai LifeSciences saRNA Synthesis Service Product and Solutions
    • 2.1.4 Maravai LifeSciences saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Maravai LifeSciences Recent Developments and Future Plans
  • 2.2 Danaher
    • 2.2.1 Danaher Details
    • 2.2.2 Danaher Major Business
    • 2.2.3 Danaher saRNA Synthesis Service Product and Solutions
    • 2.2.4 Danaher saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Danaher Recent Developments and Future Plans
  • 2.3 GenScript
    • 2.3.1 GenScript Details
    • 2.3.2 GenScript Major Business
    • 2.3.3 GenScript saRNA Synthesis Service Product and Solutions
    • 2.3.4 GenScript saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GenScript Recent Developments and Future Plans
  • 2.4 Catalent
    • 2.4.1 Catalent Details
    • 2.4.2 Catalent Major Business
    • 2.4.3 Catalent saRNA Synthesis Service Product and Solutions
    • 2.4.4 Catalent saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Catalent Recent Developments and Future Plans
  • 2.5 Lonza
    • 2.5.1 Lonza Details
    • 2.5.2 Lonza Major Business
    • 2.5.3 Lonza saRNA Synthesis Service Product and Solutions
    • 2.5.4 Lonza saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Lonza Recent Developments and Future Plans
  • 2.6 Thermo Fisher Scientific
    • 2.6.1 Thermo Fisher Scientific Details
    • 2.6.2 Thermo Fisher Scientific Major Business
    • 2.6.3 Thermo Fisher Scientific saRNA Synthesis Service Product and Solutions
    • 2.6.4 Thermo Fisher Scientific saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.7 Samsung Biologics
    • 2.7.1 Samsung Biologics Details
    • 2.7.2 Samsung Biologics Major Business
    • 2.7.3 Samsung Biologics saRNA Synthesis Service Product and Solutions
    • 2.7.4 Samsung Biologics saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Samsung Biologics Recent Developments and Future Plans
  • 2.8 Recipharm
    • 2.8.1 Recipharm Details
    • 2.8.2 Recipharm Major Business
    • 2.8.3 Recipharm saRNA Synthesis Service Product and Solutions
    • 2.8.4 Recipharm saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Recipharm Recent Developments and Future Plans
  • 2.9 Wacker
    • 2.9.1 Wacker Details
    • 2.9.2 Wacker Major Business
    • 2.9.3 Wacker saRNA Synthesis Service Product and Solutions
    • 2.9.4 Wacker saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Wacker Recent Developments and Future Plans
  • 2.10 Curia
    • 2.10.1 Curia Details
    • 2.10.2 Curia Major Business
    • 2.10.3 Curia saRNA Synthesis Service Product and Solutions
    • 2.10.4 Curia saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Curia Recent Developments and Future Plans
  • 2.11 Biomay
    • 2.11.1 Biomay Details
    • 2.11.2 Biomay Major Business
    • 2.11.3 Biomay saRNA Synthesis Service Product and Solutions
    • 2.11.4 Biomay saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Biomay Recent Developments and Future Plans
  • 2.12 ARCALIS
    • 2.12.1 ARCALIS Details
    • 2.12.2 ARCALIS Major Business
    • 2.12.3 ARCALIS saRNA Synthesis Service Product and Solutions
    • 2.12.4 ARCALIS saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 ARCALIS Recent Developments and Future Plans
  • 2.13 VectorBuilder
    • 2.13.1 VectorBuilder Details
    • 2.13.2 VectorBuilder Major Business
    • 2.13.3 VectorBuilder saRNA Synthesis Service Product and Solutions
    • 2.13.4 VectorBuilder saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 VectorBuilder Recent Developments and Future Plans
  • 2.14 Creative Biogene
    • 2.14.1 Creative Biogene Details
    • 2.14.2 Creative Biogene Major Business
    • 2.14.3 Creative Biogene saRNA Synthesis Service Product and Solutions
    • 2.14.4 Creative Biogene saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Creative Biogene Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global saRNA Synthesis Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of saRNA Synthesis Service by Company Revenue
    • 3.2.2 Top 3 saRNA Synthesis Service Players Market Share in 2025
    • 3.2.3 Top 6 saRNA Synthesis Service Players Market Share in 2025
  • 3.3 saRNA Synthesis Service Market: Overall Company Footprint Analysis
    • 3.3.1 saRNA Synthesis Service Market: Region Footprint
    • 3.3.2 saRNA Synthesis Service Market: Company Product Type Footprint
    • 3.3.3 saRNA Synthesis Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global saRNA Synthesis Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global saRNA Synthesis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global saRNA Synthesis Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global saRNA Synthesis Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America saRNA Synthesis Service Consumption Value by Type (2021-2032)
  • 6.2 North America saRNA Synthesis Service Market Size by Application (2021-2032)
  • 6.3 North America saRNA Synthesis Service Market Size by Country
    • 6.3.1 North America saRNA Synthesis Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico saRNA Synthesis Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe saRNA Synthesis Service Consumption Value by Type (2021-2032)
  • 7.2 Europe saRNA Synthesis Service Consumption Value by Application (2021-2032)
  • 7.3 Europe saRNA Synthesis Service Market Size by Country
    • 7.3.1 Europe saRNA Synthesis Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 7.3.3 France saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy saRNA Synthesis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific saRNA Synthesis Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific saRNA Synthesis Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific saRNA Synthesis Service Market Size by Region
    • 8.3.1 Asia-Pacific saRNA Synthesis Service Consumption Value by Region (2021-2032)
    • 8.3.2 China saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 8.3.5 India saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia saRNA Synthesis Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America saRNA Synthesis Service Consumption Value by Type (2021-2032)
  • 9.2 South America saRNA Synthesis Service Consumption Value by Application (2021-2032)
  • 9.3 South America saRNA Synthesis Service Market Size by Country
    • 9.3.1 South America saRNA Synthesis Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina saRNA Synthesis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa saRNA Synthesis Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa saRNA Synthesis Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa saRNA Synthesis Service Market Size by Country
    • 10.3.1 Middle East & Africa saRNA Synthesis Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia saRNA Synthesis Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE saRNA Synthesis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 saRNA Synthesis Service Market Drivers
  • 11.2 saRNA Synthesis Service Market Restraints
  • 11.3 saRNA Synthesis Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 saRNA Synthesis Service Industry Chain
  • 12.2 saRNA Synthesis Service Upstream Analysis
  • 12.3 saRNA Synthesis Service Midstream Analysis
  • 12.4 saRNA Synthesis Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on saRNA Synthesis Service. Industry analysis & Market Report on saRNA Synthesis Service is a syndicated market report, published as Global saRNA Synthesis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of saRNA Synthesis Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo